FIELD: medicine; veterinary science; immunology.
SUBSTANCE: group of inventions can be used to produce a ready-to-use combined pig vaccine. Method of producing an antigen composition involves a step of mixing PCV2 antigen with a pre-formed antigen/adjuvant complex, containing M.hyo antigen adsorbed on aluminum hydroxide, used as an adjuvant. Antigen/adjuvant complex is prepared in advance using the following steps: a) mixing the adjuvant based on aluminum hydroxide and M.hyo antigen in an aqueous carrier at a pH such that aluminum hydroxide used as an adjuvant is positively charged, wherein amount of aluminum hydroxide is from 5 to 25 % wt/wt, and b) incubation of mixture obtained at step a), providing adsorption of M.hyo antigen on aluminum hydroxide used as adjuvant, to form an antigen/adjuvant complex. Group of inventions also relates to the use of the vaccine for preventing or reducing M.hyo or PCV2 infection in pigs and related disease signs.
EFFECT: use of the given method for preparing the antigen composition enables to increase the binding of Mycoplasma hyopneumoniae antigen to the carrier.
10 cl, 4 dwg, 5 tbl, 6 ex
Title | Year | Author | Number |
---|---|---|---|
COMBINED VACCINE PCV/MYCOPLASMA HYOPNEUMONIAE | 2013 |
|
RU2615443C2 |
MYCOPLASMA HYOPNEUMONIAE VACCINE | 2013 |
|
RU2644254C2 |
COMBINED PORCINE VACCINE | 2017 |
|
RU2761453C2 |
INTRADERMAL VACCINE AGAINST PCV2 AND PRRS VIRUS INFECTION | 2017 |
|
RU2746127C2 |
COMBINATION VACCINE PCV/MYCOPLASMA HYOPNEUMONIAE/PRRS (PCV/MYCOPLASMA HYOPNEUMONIAE/PRRS COMBINATION VACCINE) | 2013 |
|
RU2644256C2 |
TREATMENT OF PIGS WITH PCV2 ANTIGEN | 2007 |
|
RU2520087C2 |
VACCINE AGAINST LAWSONIA INTRACELLULARIS AND PORCINE CIRCOVIRUS 2 | 2014 |
|
RU2672251C1 |
PORCINE CIRCOVIRUS TYPE 2 VACCINE | 2014 |
|
RU2712155C2 |
Mycoplasma hyopneumoniae AVIRULENT ADJUVANT LIVE VACCINE | 2008 |
|
RU2489164C9 |
TREATING PRDC IN GILTS | 2008 |
|
RU2522849C2 |
Authors
Dates
2020-09-08—Published
2015-12-10—Filed